Results 51 to 60 of about 11,077 (219)

Patient disease trajectories in rheumatoid arthritis patients treated with baricitinib 4-mg in 4 phase 3 clinical studies [PDF]

, 2023
Introduction: We sought to identify and compare treatment response groups based on individual patient responses (rather than group mean response) over time on the Clinical Disease Activity Index (CDAI) for rheumatoid arthritis (RA), in patients treated ...
Yushi Liu, Rubbert-Roth, Andrea, Yoshiya Tanaka, Mysler, Eduardo, Luna Sun, Holzkämper, Thorsten, Yun-Fei Chen, Andrea Rubbert-Roth, Eduardo Mysler, Bochao Jia, Thorsten Holzkämper, Tanaka, Yoshiya, Chen, Yun-Fei, Michael Weinblatt, Janet Pope, Jia, Bochao, Taylor, Peter C., Pope, Janet, Weinblatt, Michael, Peter C. Taylor, Liu, Yushi, Sun, Luna   +21 more
core   +1 more source

The relationship between the composite dietary antioxidant index and rheumatoid arthritis risk in American adults: the mediating role of BMI

Frontiers in Immunology
BackgroundThe Clinical Dietary Antioxidant Index (CDAI) is a dietary antioxidant assessment index. Although CDAI has been shown to play a role in various chronic diseases, its association with rheumatoid arthritis (RA) remains underexplored.
Tao Gao, Zhi-Yu Chen, Tao Li, Jian-Dong Tang, Xu Lin, Hai-Gang Hu, Sheng-Yu Wan, Chao Wu   +7 more
doaj   +1 more source

Physical activity modifies the association of the composite dietary antioxidant index with all-cause mortality in the US osteoarthritis population

Frontiers in Public Health, 2023
BackgroundIt remains unclear how antioxidant intake affects all-cause mortality in osteoarthritis (OA) patients. In this prospective cohort study, we aim to explore the association of the Composite Dietary Antioxidant Index (CDAI) with all-cause ...
Yiwei Zhang, Zhengwei Duan, Hengli Lu, Guanghua Lu, Yuesong Fu, Guodong Li, Sen Wang   +6 more
doaj   +1 more source

Efficacy and Safety of Cannabis Derivates and Their Synthetic Analogs. Overview of Systematic Reviews

Phytotherapy Research, EarlyView.
ABSTRACT The use of medicinal products derived from cannabis and its synthetic analogues has grown in recent years for various health conditions, which led to an increase in systematic reviews (SR) on the topic. The objective of this overview was to identify, synthesize, and critically appraise the evidence from SR on the benefits and harms of cannabis
Rafael Leite Pacheco, Daniela Fortunato Rêgo, Carolina de Oliveira Cruz Latorraca, Marco Aurelio de Carvalho Nascimento, André Bastos Daher, Rachel Riera   +5 more
wiley   +1 more source

The inverse associations between composite-dietary-antioxidant-index and sarcopenia risk in US adults

Frontiers in Endocrinology
BackgroundIt remains unknown whether composite-dietary-antioxidant-index (CDAI) is associated with the risk of sarcopenia. This study investigated the association of CDAI with sarcopenia risk among general US adults.MethodsA total of 10,093 participants ...
Kang Wang, Qin Zhou, Zhongbiao Jiang, Shiping Liu, Hanfen Tang   +4 more
doaj   +1 more source

Natural Polysaccharides for Rheumatoid Arthritis Therapy: Mechanism, Drug Delivery and Clinical Application

Phytotherapy Research, EarlyView.
Schematic overview of the experimental models, therapeutic mechanisms, drug delivery systems, and clinical potential of natural polysaccharides in rheumatoid arthritis. ABSTRACT Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized primarily by chronic synovitis.
Luxin Li, Junnan Li, Guangzhi Li, Lili Huang, Tiantian Wen, Yanying Li, Yan Sun, Zhenqiang Liu, Qingshan Chen, Lili Zhang, Tiangang Lu, Ruiyan Wu, Haixue Kuang, Xiaochi Ma, Yan Liu   +14 more
wiley   +1 more source

Ultrasound and multi-biomarker disease activity score for assessing and predicting clinical response to tofacitinib treatment in patients with rheumatoid arthritis [PDF]

, 2020
BackgroundMusculoskeletal ultrasound (MSUS) and the multi-biomarker disease activity (MBDA) score are outcome measures that may aid in the management of rheumatoid arthritis (RA) patients. This study evaluated tofacitinib response by MSUS/MBDA scores and
Razmjou, Amir A, Kermani, Tanaz, Ranganath, Veena K, Brook, Jenny, Kaeley, Gurjit, Elashoff, David, Choi, Soo, Gurjit Kaeley, Soo Choi, Tanaz Kermani, Veena K. Ranganath, David Elashoff, Jenny Brook, Amir A. Razmjou   +13 more
core   +1 more source

AB0119 DISCORDANCE OF RAPID3 AND CDAI IN RHEUMATOID ARTHRITIS [PDF]

Annals of the Rheumatic Diseases, 2021
L.A. Ramrattan, Z. Vaghaiwalla, S. Singh, K. Ramsubeik, M. Thway, G. Kaeley   +5 more
openaire   +1 more source

Clinical predictors of response to methotrexate in patients with rheumatoid arthritis: A systematic review

Rheumatology &Autoimmunity, EarlyView.
This review integrates clinical, immunological, genetic, and multi‐omic evidence, highlighting dynamic inflammatory and adenosine‐pathway biomarkers and reinforcing treat‐to‐target principles as the most actionable framework for personalized methotrexate therapy.
Joana Ramos Rodrigues, Helena Margarida de Miranda Lemos Romão Donato, Soraia Raquel Loureiro Azevedo, Luís Miguel da Silva Pires, Luís Pedro Bolotinha de Sousa Inês, Manuel Augusto Nunes Vicente Passos Morgado, Ana Filipa de Sousa Pestana Mourão   +6 more
wiley   +1 more source

Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis

Терапевтический архив, 2013
AIM: To evaluate the impact of tocilizumab (TCZ) therapy on the level of matrix metalloproteinase-3 (MMP-3) 4, 24, and 48 weeks after treatment initiation in relation to the clinical efficiency of TCZ therapy by the Disease Activity Score (DAS28), the ...
A S Avdeeva, E N Aleksandrova, A A Novikov, M V Cherkasova, E Iu Panasiuk, E L Nasonov   +5 more
doaj